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Eating behavior is determined by a balance of memories
in terms of reward and punishment to satisfy the urge to
consume food. Refilling empty energy stores and hedo-
nistic motivation are rewarding aspects of eating.
Overfeeding, associated adverse GI effects, and obesity
implicate punishment. In the current review, evidence is
given for the hypothesis that bariatric surgery affects
control over eating behavior. Moreover, any caloric over-
load will reduce the feeling of satiety. Durable weight
loss after bariatric surgery is probably the result of a
new equilibrium between reward and punishment,
together with a better signaling of satiation due to bene-
ficial metabolic changes.We propose to introduce three
main treatment goals for bariatric surgery: 1) acceptable
weight loss, 2) improvement of eating control, and 3)
metabolic benefit. To achieve this goal, loss of 50% to
70% of excess weight will be appropriate (i.e. 30% to
40% loss of initial weight), depending on the degree of
obesity prior to operation.
Key words: Bariatric surgery, control, eating behavior,
hunger, regulation, satiety, safe surgery
Introduction
The public health situation of many industrialized
countries is jeopardized by the increasing incidence
of obesity and related cardiovascular disease.1,2 The
alarming situation is clearly related to our modern
way of living, implicating ad libitum access to food
and sedentary lifestyle. The prevalence of obesity
increases every year and overrules our tightly con-
trolled energy homeostasis, which tries to keep body
weight within narrow boundaries.3,4 Nationwide
campaigns against obesity and associated cardiovas-
cular disease are mainly focused on signs and symp-
toms of the metabolic syndrome. For example, the
diagnostic criteria proposed by the American
National Cholesterol Education Program-Adult
Treatment Panel III (NCEP-ATPIII) are understand-
able and can be managed with caloric restriction,
exercise, and modern effective drugs.5 However,
many motivated obese patients try hard to reduce
weight but gradually lose control of eating behavior,
become disappointed, and finally undergo bariatric
surgery. Notably, each surgical technique has its spe-
cific advantages and drawbacks. For example,
laparoscopic adjustable gastric banding (LAGB) is a
restrictive technique, which is appropriate for
patients with a body mass index (BMI) <50 kg/m2
and without extreme eating disorders. In this respect,
a long-term follow-up study among individuals who
underwent LAGB showed ‘treatment failure’ in
about 37% after 7 years.6 On the other hand, gastric
bypass (GBP) and biliopancreatic diversion (BPD)
combined with restrictive techniques are clearly
more effective to maintain durable weight loss.7
Because there are no safety follow-up data >10
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sorption has earned the reputation as the ‘gold stan-
dard’ against all other procedures. 
The current review explains the critical role of
bariatric surgery to improve eating behavior and reset
metabolism. In the first place, weight loss surgery
emphasizes punishment after too much or too fast food
consumption. Secondly, since intake of inappropriate-
ly high amounts of calories suppresses satiety, too
much food is regarded as a metabolic disadvantage.
We propose to perform weight loss surgery for what
most people accept as cosmetically acceptable weight
reduction, improvement of eating control, and a bene-
ficial change of the balance between hunger and sati-
ety. In other words, behavioral and medical arguments
are brought together to reason weight loss surgery.
Eating Behavior
Associative Learned Networks that
Compose Eating Behavior
The conditioned reflex of eating behavior was funda-
mentally pioneered by Pavlov.8 In his classic "sham"
feeding studies performed on dogs with an
esophageal stoma and a gastric fistula, Pavlov
demonstrated that food was a prompt and powerful
stimulant of gastric secretion. This so-called ‘cephal-
ic phase’ of gastric acid secretion occurred despite
the fact that the ingested food entered the dog’s
mouth and pharynx without reaching the stomach.
Pavlov went on to demonstrate that dissecting the
vagus nerve just above the diaphragm abolished this
response to sham feeding. Sham feeding in humans
by chewing and expectorating food without swallow-
ing revealed similar reproducible results and even
thinking about food is a strong stimulant of gastric
acid production.9,10 Sham feeding is a typical exam-
ple of a conditioned stimulus that goes along with a
paired digestive response (cue). Beyond simple cues
related to motor and secretory responses, there are far
more complex  interacting cues that all together form
a memorized network of learned stimulus-response
interactions.11 Eating behavior is primarily condi-
tioned by the simple 'hunger' cue and on top of it by
a complex network of memories related to eating.
Fundamentally, this network is critical to condition
individuals to fill their empty energy stores.12
Eating for Pleasure (Hedonism)
Eating behavior is also, at least in part, attributable to
the assault by daily food-related stimuli while there are
no physical energy requirements.13,14 For example,
today's continuous bombardment of food-related cues
by advertisements about food and catchy jiggles from
fast-food restaurants tightens our eating behavior net-
works, stimulates overfeeding and overrides the natu-
ral cues of satiety.15 Obviously, our original goals to
eat in order to fill energy stores become replaced by
eating behavior that satisfies hedonistic desires.16 The
fulfilment of biological requirements as well as hedo-
nistic drives leads to satisfaction using our reward cir-
cuitry, which in part resides in dopaminergic circuits in
the nucleus accumbens.17-19 The stronger the reward
value of a specific food-related cue, which is in part
conveyed by its prediction from previously memorized
experiences, the stronger the demand to get more of it,
i.e. ‘wanting’. Palatable food has a high reward value,
i.e. ‘liking’, and a lot of its ingestion may even lead to
addictive behavior, craving and subsequent obesity.20
Research points to the direction that 'wanting' is medi-
ated by dopaminergic neurotransmission, whereas ‘lik-
ing’ is mediated by opioid pathways.21 In humans, it
has been shown that palatable food is capable of
enhancing ‘wanting’, while it hardly affects ‘liking’.22
This situation resembles that of chronic substance
abuse, meaning craving without liking.
Hunger Regulation
Feedback between Body Fat and Brain 
Besides the behavioral aspects of eating, hunger and
satiety are mainly centrally regulated by energy home-
ostasis. This mechanism is designed to keep our body
weight tightly regulated. In order to gain weight,
adaptations of energy homeostasis are essential to
alter its set-point. Moreover, weight gain and obesity
are associated with insulin resistance, which raises the
fundamental question whether adaptations of energy
homeostasis are linked to insulin resistance. By defi-
nition, energy homeostasis is the biological process in
which energy intake is matched to energy expenditure
over time, to promote stability of body fuel that is
stored in the form of fat. The idea of an ‘adiposity neg-
ative feedback control system’ was for the first time
Schweitzer et al
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being the regulated variable, stands at the bottom of
this system, whereas food intake is the major determi-
nant of how much body fat will be stored.
It was furthermore hypothesized that efferent cir-
culating signals, produced in proportion to fat mass,
would act in the brain to slow down food intake. In
this concept, starvation or drastic lowering of food
intake diminishes body fat, including its negative
feedback signals, thereby activating the brain to
stimulate hunger.23 Today, there is solid evidence
that hypothalamic centers control the regulation of
feeding behavior and energy homeostasis.24
Moreover, insulin is a potential mediator of adipos-
ity-related negative feedback signaling.25-27 The hor-
mone circulates in proportion to fat mass, crosses the
blood-brain barrier, and acts on key brain pathways
that are connected to the liver by efferent neuronal
input. In the brain, insulin directs the vagus nerve to
inhibit glycogenolysis in the liver in a situation of
energy store repletion.27,28 Insulin infusion directly
into the brain decreases appetite and food intake,
leading to weight loss. On the contrary, artificial dis-
ruption of receptor signaling for insulin in key brain
areas increases hepatic glucose production, appetite,
food intake and leads to weight gain.29,30
Furthermore, laboratory animals lacking the insulin
receptor substrate-2 (IRS-2) have increased food
intake and obesity.31 These findings were the first evi-
dence to suggest a role for ‘brain insulin signaling’ in
the control of food intake and energy homeostasis.
Parallel to insulin resistance, leptin is increasingly
secreted by adipocytes and acts as the second pow-
erful mediator of adiposity-related negative feedback
signaling. Like insulin, leptin directly infused into
the brain decreases appetite, food intake and body
weight, whereas a defect of leptin signaling in key
brain areas increases appetite, food intake and body
weight.32,33 Moreover, evidence suggests that central
leptin action, as well as insulin, regulates energy
homeostasis via neuronal pathways that are partly
overlapping, as previously reviewed.34
Common Signal Transduction in the
Regulation of Hunger and Satiety 
Brain-specific insulin receptors, involved in energy
homeostasis regulation, are mainly located in the area
of the medio-basal hypothalamus, the portion that
includes the arcuate nucleus (ARC).35 Insulin binds to
its receptor and generates signal transduction by the
intracellular signaling pathway known as insulin
receptor substrate phosphatidylinositol 3-kinase (IRS/
PI 3-kinase).36 Basically, insulin binds to the extracel-
lular domain of its receptor and activates tyrosine
kinase activity, thereby creating a binding site for dif-
ferent isoforms of the IRS protein family.37,38 The IRS
isoforms that become phosphorylated act as docking
proteins for several proteins including PI 3-kinase.39
Notably, a part of leptin signal transduction in hypo-
thalamic key areas is also using IRS/ PI 3-kinase.40,41
The leptin receptor is a cytokine receptor that
leads to the activation of a signaling cascade involv-
ing Janus kinase and signal transducer and activator
of transcription 3 (Jak-STAT3).42,43 Interestingly,
(Jak-STAT3) signaling shares connectivity with
IRS/ PI 3-kinase signaling, as Jak also uses the IRS
protein family as substrate.36,41,44 For this reason it is
believed that IRS/ PI 3-kinase signal transduction in
ARC acts as relay for both hormones,  insulin and
leptin, in the regulation of energy homeostasis.40,41
Insulin and leptin signal transduction in ARC tunes
the equilibrium between feeding behavior inhibiting
peptides, i.e. proopiomelanocortin (POMC) and
cocaine and amphetamine-regulated transcript
(CART) and feeding behavior promoting peptides,
i.e. neuropeptide Y (NPY) and agouti-related pro-
tein (AGRP), as previously reviewed.45-49
Diminished Satiety Feelings due to
Nutrient Excess
The notion that similar hypothalamic signal trans-
duction systems are involved in the regulation of
energy homeostasis and insulin sensitivity raises the
question how nutrient excess is involved in this reg-
ulation. Obese individuals who have recently lost
substantial amounts of weight became insulin-
resistant when put on a short-term hypercaloric diet,
while lean individuals remained sensitive to insulin
under identical circumstances.50 This phenomenon
is explained, at least to some extent, by the ability of
nutrient excess to block the activation of IRS/ PI 3-
kinase signal transduction.51 Indeed, blunting of sig-
nal transduction by macronutrients has been
observed in peripheral tissues as well as in brain tis-
sue.29,52,53 Lastly, cumulating data have indicated
that free fatty acids (FFAs) and glucose are each
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and of reducing hepatic glucose production. These
macronutrients were directly infused in the ARC
region of laboratory animals.34
Defining Treatment Success
Medical Weight Loss and Individual
Expectations
The percentage excess weight loss [i.e. weight
loss/(total weight - normal weight)] after bariatric
surgery is usually 50 to 70%, depending on the total
intestinal absorption capacity.7 GBP is most widely
practised, followed by LAGB, and least commonly
by BPD with gastric restriction.56 Sufficient residual
absorption surface after surgery remains critical,
because we are still inadequately informed about the
health consequences of chronic malabsorption.55
Nevertheless, the number of patients happy to
undergo primarily malabsorptive procedures is tes-
tament to the desperation faced by obese people. In
fact, many individuals overvalue thinness in pursuit
of cosmetic rather than medical changes and under-
score future opportunities through their operation in
terms of  'improved control of eating behavior' and
a beneficial change of energy homeostasis. 
Guidelines for surgical treatment of morbidly
obese individuals have been previously formulated,
however, without clearly defined treatment goals.58 A
widely accepted medical goal is 10% weight loss in 6
months, but many patients are more ambitious about
the amount of weight they want to lose.57 On average,
obese women with a BMI of 36.3±4.3 kg/m2 report-
ed that their goal was to lose 32% of their initial
weight. These women also reported that their
“dream” was to lose 38%, they would be “happy”
with 31%, they would “accept” 25%, but they would
be “disappointed” with 17% weight loss. Therefore,
acceptable weight loss for most subjects is 2 to 3
times more than that achieved after medical therapy.58
Realistic Targets after Bariatric Surgery
In a large Swedish cohort of men and women who were
treated either with LAGB, vertical banded gastroplasty
(VBG) or GBP, early and 10 years follow-up data were
collected.59 The absolute mean weight loss was 23% at
2 years and 16% at 10 years follow-up. Early weight
loss and 10-year results in subgroups were: LAGB
-21±10%, VBG -26±9%, GBP -38±7%, and LAGB
-13±13%, VBG -17±11%, and GBP -25±11%, respec-
tively. In other words, these data demonstrate that
‘acceptable’ or ~25% loss of initial weight can be
achieved with bariatric surgery. Moreover, the mean
BMI of the Swedish cohort was 41.3±4.0 kg/m2, which
automatically means that patients must have lost 50 to
70% of their excess weight (Table 1). Furthermore,
excess weight loss after primarily malabsorptive sur-
gery, i.e. with a long biliopancreatic limb combined
with a distal gastrectomy60 or with a 75% vertical gas-
trectomy61-63 will result into ~70 to 90% loss of excess
weight, which is in agreement with  some 40% of the
initial weight (in BMIs exceeding 40 kg/m2, Table 1).
Weight Loss after Effective and Safe
Bariatric Surgery
In contrast to restrictive techniques, primarily mal-
absorptive surgery usually leads to negligible weight
regain, depending on the length of the common
channel.64-68 The question remains what type of sur-
gery is effective in terms of control and metabolism,
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Table 1. 50 to 70% loss of excess weight corresponds to 25% loss of initial weight for BMIs 35-45 kg/m2, and
to 40% loss of initial weight for BMIs >45 kg/m2
Calculated weight loss in a subject of height 1.70 m
Weight  BMI  40% weight  25% weight  50% loss of  70% loss of
(kg) (kg/m2) loss (kg) loss (kg) excess weight (kg) excess weight (kg)
190 65 115 143 130 113
160 55 95 120 115 98
130 45 78 98 100 88
115 40 70 85 93 83
100 35 60 75 85 80cosmetically acceptable, and without unforeseen
health risks. There are no scientific answers unfortu-
nately, because long-term safety data have not been
published. Observational studies about safety issues
after gastrectomy are mainly about the issue of long-
term bone health.  Early gastric cancer is frequently
observed in the Japanese population and treated with
total gastrectomy at an early stage. It appears that the
risk to sustain osteoporotic fractures is positively
associated with post gastric resection.
In order to be cautious, we advocate ‘safe sur-
gery’, meaning effective techniques resulting in
‘acceptable’ weight loss, i.e. 25% of initial weight
loss down to a BMI between 30 and 40 kg/m2,
depending on the baseline BMI.68 In this concept,
individuals with an initial BMI of, for example, 55
kg/m2 should reduce to 35 kg/m2, while in the case
of an  initial BMI of, for example, 43 kg/m2 a reduc-
tion to 30 kg/m2 would do very well. These amounts
of weight loss are in agreement with 50 to 70% loss
of excess weight (Table 2). Until today, it is
unknown whether BMIs ≤30 kg/m2, which are in
agreement with >90% loss of excess weight, are
safe in the long-term (Table 3). To convince
patients, it may be helpful to argue that their surgery
is meant to lose weight by improving their eating
control and to optimize metabolism. People should
undergo surgery aiming to realize an acceptable
body weight and, albeit sometimes difficult to con-
vince patients, to avoid unpredictable health risks
due to procedures for cosmetic dreams. 
In conclusion, the two main ways to become fat,
i.e. obesogenic environments wherein people over-
feed themselves with excess calories with detrimental
metabolic effects, and are sedentary, are effectively
treated with a bariatric  operation. Yet, no evidence is
available about the safest technique for individual
patients. Bariatric surgery, particularly the restrictive
part, is useful to restore the balance between reward
and punishment, thereby improving eating behavior
and energy homeostasis. These educational and
metabolic aspects prevail above cosmetic arguments,
which could lead to a radical operation with unpre-
dictable effects later in life. Based on common sense,
we propose to target any operation to a reduction of
30 to 40% of initial weight or 50 to 70% of excess
weight. Prospective controlled studies concerning
long-term efficacy and safety aspects are critical for
algorithms for tailor-made bariatric surgery. 
Surgery for Better Eating Control and Metabolism
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Table 2. Calculated weight loss after weight reduction down to 75 kg (meaning a BMI of 25 kg/m2) expressed
as initial or excess weight loss
Weight loss to a BMI of 25 kg/m2 in a subject of height 1.70 m
Weight  BMI before Weight  BMI after  Loss of initial  Loss of excess
(kg) surgery (kg/m2) (kg) surgery (kg/m2) weight (%) weight (%)
190 65 75 25 61 96
160 55 75 25 54 94
130 45 75 25 43 92
115 40 75 25 37 89
Table 3. Calculated weight loss after weight reduction to 40 in heaviest, to 35 in middle heavy, and to 30 kg/m2
in least heavy individuals, expressed as initial or excess weight loss, at height 1.70 m
Weight loss to a BMI of 30-40 kg/m2 in a subject of height 1.70 m
Weight  BMI before Weight  BMI after Loss of initial  Loss of excess
(kg) surgery (kg/m2) (kg) surgery (kg/m2) weight (%) weight (%)
190 65 115 40 39 63
160 55 100 35 38 67
130 45 88 30 32 70
115 40 88 30 23 61References
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